DOCSLIB.ORG

R Graphics Output

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
R Graphics Output Running Enrichment Score (RES) Gene Set506:FETAL_LIVER_ENRICHED_TRANSCRIPTION_FACTORS −1.0 −0.8 −0.6 −0.4 −0.2 0.0 0.2 0 "G1[B_MLL]" 2000 Number ofgenes: 12930(inlist),70geneset) Zero crossingat7115 4000 Gene ListIndex 6000 8000 Peak at11533 Peak 10000 "G2[Non_B_MLL]" 12000 P(ES) 0 1 2 3 4 5 6 Neg. ES"G2[Non_B_MLL]" ES = −0.375 NES = −1.53 Nom. p−val= 0.0233FWER=1FDR=0.383 ES =−0.375NES =−1.53Nom.p−val= −0.4 Gene SetNullDistribution −0.2 Observed GeneSetESvalue Gene SetNullDensity ES 0.0 Pos. ES:"G1[B_MLL]" Pos. 0.2 0.4 SMARCD1 GTF2IRD1 HIST1H4A DNMT3A RFXANK DNMT3B TCERG1 H2AFY2 STAT5A ZNF282 HMGN2 ZNF238 HMGB1 NCOA3 PQBP1 MEF2C MEF2A RUNX1 HDAC1 MYST3 NFKB1 PROX1 BAZ1B NR2C2 NR1H3 H2AFZ GATA2 SOX13 SOX15 PHTF1 RNF14 G1[B_MLL] SP100 ZFP64 DDIT3 SIRT2 HHEX MED6 SPOP FOSB EGR3 EGR1 BRD4 Class PHC2 NSD1 PMF1 RBX1 UBTF RNF4 NRF1 RNF7 ELK3 ELK4 ETV5 ETS1 TFE3 MDFI ELF1 SPIB IFI35 GFI1 MYC SPI1 DBP ILF2 FOS MLL SRF HLF NMI ID4 JD.ALD057.v5.U133A.CEL JD.ALD232.v5.U133A.CEL JD.ALD294.v5.U133A.CEL JD.ALD385.v5.U133A.CEL JD0080.ALL.v5.U133A.CEL JD.ALD052.v5.U133A.CEL JD.ALD078.v5.U133A.CEL JD.ALD433.v5.U133A.CEL JD0084.ALL.v5.U133A.CEL swp350.u133a.CEL JD.ALD180.v5.U133A.CEL JD0124.ALL.v5.U133A.CEL JD0284.ALL.v5.U133A.CEL JD.ALD009.v5.U133A.CEL JD0349.ALL.v5.U133A.CEL JD0181.ALL.v5.U133A.CEL JD.ALD509.v5.U133A.CEL JD0239.ALL.v5.U133A.CEL JD0186B.ALL.v5.U133A.CEL JD0032.ALL.v5.U133A.CEL JD0361.ALL.v5.U133A.CEL JD0336.ALL.v5.U133A.CEL JD0300.RR.ALL.v5.U133A.CEL JD0267.ALL.v5.U133A.CEL JD0323.ALL.v5.U133A.CEL JD0150.ALL.v5.U133A.CEL JD0059.ALL.v5.U133A.CEL JD0123.ALL.v5.U133A.CEL JD0056.ALL.v5.U133A.CEL GenesinGeneSet HeatMapfor JD0058.ALL.v5.U133A.CEL JD0139.ALL.v5.U133A.CEL JD0107.ALL.v5.U133A.CEL JD0109.ALL.v5.U133A.CEL JD0085.ALL.v5.U133A.CEL JD0253.ALL.v5.U133A.CEL JD0426.ALL.v5.U133A.CEL JD0286.ALL.v5.U133A.CEL JD0282.ALL.v5.U133A.CEL JD0318.ALL.v5.U133A.CEL JD.ALD096.v5.U133A.CEL JD.ALD108.v5.U133A.CEL JD0066.ALL.v5.U133A.CEL JD0016.ALL.v5.U133A.CEL JD0048.ALL.v5.U133A.CEL JD0086.ALL.v5.U133A.CEL JD0193.ALL.v5.U133A.CEL JD0280.ALL.v5.U133A.CEL JD0320.ALL.v5.U133A.CEL JD0330.ALL.v5.U133A.CEL JD0328.ALL.v5.U133A.CEL JD0250.ALL.v5.U133A.CEL JD0220.ALL.v5.U133A.CEL JD0332.R.ALL.v5.U133A.CEL G2[Non_B_MLL] JD0304.ALL.v5.U133A.CEL JD0395.ALL.v5.U133A.CEL JD0341.ALL.v5.U133A.CEL JD0263.ALL.v5.U133A.CEL JD0364.ALL.v5.U133A.CEL JD0437.ALL.v5.U133A.CEL JD0436.ALL.v5.U133A.CEL JD0382.ALL.v5.U133A.CEL JD0354.ALL.v5.U133A.CEL JD0342.ALL.v5.U133A.CEL JD0238.ALL.v5.U133A.CEL JD0247.ALL.v5.U133A.CEL JD0168.B.ALL.v5.U133A.CEL JD0264.ALL.v5.U133A.CEL JD0390.ALL.v5.U133A.CEL JD0423.ALL.v5.U133A.CEL JD0432.ALL.v5.U133A.CEL JD0344.ALL.v5.U133A.CEL JD0039.ALL.v5.U133A.CEL JD0255.ALL.v5.U133A.CEL JD0297.R.ALL.v5.U133A.CEL JD0421.ALL.v5.U133A.CEL JD0408.ALL.v5.U133A.CEL JD0396.ALL.v5.U133A.CEL JD0108.ALL.v5.U133A.CEL JD0146.ALL.v5.U133A.CEL JD0360.ALL.v5.U133A.CEL JD0367.ALL.v5.U133A.CEL JD0314.ALL.v5.U133A.CEL JD0420.ALL.v5.U133A.CEL JD0343.ALL.v5.U133A.CEL JD0173.ALL.v5.U133A.CEL JD0258.ALL.v5.U133A.CEL JD0287.ALL.v5.U133A.CEL JD0185B.ALL.v5.U133A.CEL JD0103.ALL.v5.U133A.CEL JD0425.ALL.v5.U133A.CEL JD0225.ALL.v5.U133A.CEL JD0433.ALL.v5.U133A.CEL JD0431.ALL.v5.U133A.CEL JD0252.ALL.v5.U133A.CEL JD0188.ALL.v5.U133A.CEL JD0272.ALL.v5.U133A.CEL JD0289.ALL.v5.U133A.CEL JD0407.ALL.v5.U133A.CEL JD0257.ALL.v5.U133A.CEL JD0095.ALL.v5.U133A.CEL JD0226.ALL.v5.U133A.CEL JD.ALD388.v5.U133A.CEL JD.ALD428.v5.U133A.CEL JD0154.ALL.v5.U133A.CEL JD.ALD494.v5.U133A.CEL JD.ALD035.v5.U133A.CEL JD.ALD039.v5.U133A.CEL JD.ALD391.v5.U133A.CEL JD.ALD264.v5.U133A.CEL JD.ALD386.v5.U133A.CEL JD.ALD387.v5.U133A.CEL JD.ALD389.v5.U133A.CEL JD.ALD390.v5.U133A.CEL JD.ALD008.v5.U133A.CEL JD0206.ALL.v5.U133A.CEL JD0102.ALL.v5.U133A.CEL JD0129.ALL.v5.U133A.CEL JD.ALD613.v5.U133A.CEL JD0192.ALL.v5.U133A.CEL JD0260.ALL.v5.U133A.CEL JD0036.ALL.v5.U133A.CEL JD0381.ALL.v5.U133A.CEL JD0291.RR.ALL.v5.U133A.CEL JD0203.ALL.v5.U133A.CEL JD0246.ALL.v5.U133A.CEL JD0274.ALL.v5.U133A.CEL JD0334.ALL.v5.U133A.CEL.
Load more

Recommended publications
  • Transcriptional Regulatory Networks in Neocortical Development
    Review From trans to cis: transcriptional regulatory networks in neocortical development 1 1 1,2 Mikihito Shibata , Forrest O. Gulden , and Nenad Sestan 1 Department of Neurobiology and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510, USA 2 Department of Psychiatry and Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale School of Medicine, New Haven, CT 06510, USA Transcriptional mechanisms mediated by the binding of tions among TFs and CREs form the central core of tran- transcription factors (TFs) to cis-acting regulatory ele- scriptional regulatory networks (TRNs) (Box 1) [1]. ments (CREs) in DNA play crucial roles in directing gene Interactions between TFs and CREs are complex, dynam- expression. While TFs have been extensively studied, ic,andmodulatedbyvariousepigeneticprocesses[12].While less effort has gone towards the identification and func- individual CREs may be regulated by the competitive or tional characterization of CREs and associated epigenet- cooperative binding of many TFs, multiple CREs may also ic modulation. However, owing to methodological and confer transcriptional control over the expression of any analytical advances, more comprehensive studies of single gene [12]. Furthermore, TFs and CREs regulate regulatory elements and mechanisms are now possible. transcription together with their cognate transcriptional We summarize recent progress in integrative analyses of cofactors, chromatin regulators, epigenetic modifications, these regulatory components in the development of the RNA-binding proteins, and non-coding RNAs [2,13]. This cerebral neocortex, the part of the brain involved in combinatorial and multi-level transcriptional regulation cognition and complex behavior. These studies are greatly increases the complexity of gene expression regula- uncovering not only the underlying transcriptional reg- tion, facilitating the unique spatio-temporal patterns nec- ulatory networks, but also how these networks are essary for tissue development and function [3].
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • Apoptotic Cells Inflammasome Activity During the Uptake of Macrophage
    Downloaded from http://www.jimmunol.org/ by guest on September 29, 2021 is online at: average * The Journal of Immunology , 26 of which you can access for free at: 2012; 188:5682-5693; Prepublished online 20 from submission to initial decision 4 weeks from acceptance to publication April 2012; doi: 10.4049/jimmunol.1103760 http://www.jimmunol.org/content/188/11/5682 Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic Cells Marie E. Benoit, Elizabeth V. Clarke, Pedro Morgado, Deborah A. Fraser and Andrea J. Tenner J Immunol cites 56 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2012/04/20/jimmunol.110376 0.DC1 This article http://www.jimmunol.org/content/188/11/5682.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 29, 2021. The Journal of Immunology Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic Cells Marie E.
    [Show full text]
  • Strand Breaks for P53 Exon 6 and 8 Among Different Time Course of Folate Depletion Or Repletion in the Rectosigmoid Mucosa
    SUPPLEMENTAL FIGURE COLON p53 EXONIC STRAND BREAKS DURING FOLATE DEPLETION-REPLETION INTERVENTION Supplemental Figure Legend Strand breaks for p53 exon 6 and 8 among different time course of folate depletion or repletion in the rectosigmoid mucosa. The input of DNA was controlled by GAPDH. The data is shown as ΔCt after normalized to GAPDH. The higher ΔCt the more strand breaks. The P value is shown in the figure. SUPPLEMENT S1 Genes that were significantly UPREGULATED after folate intervention (by unadjusted paired t-test), list is sorted by P value Gene Symbol Nucleotide P VALUE Description OLFM4 NM_006418 0.0000 Homo sapiens differentially expressed in hematopoietic lineages (GW112) mRNA. FMR1NB NM_152578 0.0000 Homo sapiens hypothetical protein FLJ25736 (FLJ25736) mRNA. IFI6 NM_002038 0.0001 Homo sapiens interferon alpha-inducible protein (clone IFI-6-16) (G1P3) transcript variant 1 mRNA. Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 GALNTL5 NM_145292 0.0001 (GALNT15) mRNA. STIM2 NM_020860 0.0001 Homo sapiens stromal interaction molecule 2 (STIM2) mRNA. ZNF645 NM_152577 0.0002 Homo sapiens hypothetical protein FLJ25735 (FLJ25735) mRNA. ATP12A NM_001676 0.0002 Homo sapiens ATPase H+/K+ transporting nongastric alpha polypeptide (ATP12A) mRNA. U1SNRNPBP NM_007020 0.0003 Homo sapiens U1-snRNP binding protein homolog (U1SNRNPBP) transcript variant 1 mRNA. RNF125 NM_017831 0.0004 Homo sapiens ring finger protein 125 (RNF125) mRNA. FMNL1 NM_005892 0.0004 Homo sapiens formin-like (FMNL) mRNA. ISG15 NM_005101 0.0005 Homo sapiens interferon alpha-inducible protein (clone IFI-15K) (G1P2) mRNA. SLC6A14 NM_007231 0.0005 Homo sapiens solute carrier family 6 (neurotransmitter transporter) member 14 (SLC6A14) mRNA.
    [Show full text]
  • YKL-40 Downregulation Is a Key Factor to Overcome Temozolomide Resistance in a Glioblastoma Cell Line
    ONCOLOGY REPORTS 32: 159-166, 2014 YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line YASUTO AKIYAMA1,3*, TADASHI ASHIZAWA1*, MASARU KOMIYAMA1, HARUO MIYATA1, CHIE OSHITA1, MAHO OMIYA1, AKIRA IIZUKA1, AKIKO KUME1, TAKASHI SUGINO2, NAKAMASA HAYASHI3, KOICHI MITSUYA3, YOKO NAKASU3 and KEN YAMAGUCHI1 1Immunotherapy Division, Shizuoka Cancer Center Research Institute; Divisions of 2Pathology and 3Neurosurgery, Shizuoka Cancer Center Hospital, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan Received March 6, 2014; Accepted April 22, 2014 DOI: 10.3892/or.2014.3195 Abstract. The frequent recurrence of glioblastoma multi- resistant cells in vitro and in vivo. Additionally, YKL-40 gene forme (GBM) after standard treatment with temozolomide inhibition exhibited significant suppression of the invasive (TMZ) is a crucial issue to be solved in the clinical field. activity and particularly partially restored the sensitivity to O6-methylguanine-DNA methyltransferase (MGMT) is TMZ. Therefore, YKL-40 may be a novel key molecule in considered one of the major mechanisms involved in TMZ addition to MGMT, that is responsible for TMZ resistance in resistance. However, some important mechanisms for TMZ glioblastoma cell lines and could be a new target to overcome resistance other than MGMT have recently been identified. In TMZ resistance in recurrent glioblastomas in the future. the present study, we established a TMZ-resistant (TMZ-R) U87 glioblastoma cell line in vitro and in vivo and investi- Introduction gated novel targeting molecules other than MGMT in those cells. The TMZ-R U87 glioblastoma cell line was established Glioblastoma multiforme (GBM) is the most malignant and in vitro and in vivo.
    [Show full text]
  • Differential Expression of Id Genes and Their Potential Regulator Znf238 In
    Differential expression of id genes and their potential regulator znf238 in zebrafish adult neural progenitor cells and neurons suggests distinct functions in adult neurogenesis Nicolas Diotel, Tanja Beil, Uwe Strähle, Sepand Rastegar To cite this version: Nicolas Diotel, Tanja Beil, Uwe Strähle, Sepand Rastegar. Differential expression of id genes and their potential regulator znf238 in zebrafish adult neural progenitor cells and neurons suggests dis- tinct functions in adult neurogenesis. Gene Expression Patterns, Elsevier, 2015, 19 (1-2), pp.1-13. 10.1016/j.gep.2015.05.004. hal-01692747 HAL Id: hal-01692747 https://hal.univ-reunion.fr/hal-01692747 Submitted on 6 Feb 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Differential expression of id genes and their potential regulator znf238 in zebrafish adult neural progenitor cells and neurons suggests distinct functions in adult neurogenesis Nicolas Diotela,b,c,*, Tanja Beila, Uwe Strahle€ a, Sepand Rastegara,* aKarlsruhe Institute of Technology, Campus Nord, Institute of Toxicology and Genetics, Karlsruhe, Germany bInserm, UMR 1188 Diabete atherothrombose Therapies Reunion Ocean Indien (DeTROI), Plateforme CYROI, Sainte-Clotilde, F-97490, France cUniversitedeLaReunion, UMR 1188, Sainte-Clotilde, F-97490, France abstract Teleost fish display a remarkable ability to generate new neurons and to repair brain lesions during adulthood.
    [Show full text]
  • Genome-Wide Transcriptional Analysis of Carboplatin Response in Chemosensitive and Chemoresistant Ovarian Cancer Cells
    1605 Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells David Peters,1,2 John Freund,2 and Robert L. Ochs2 variety of disease processes, including cancer. Patterns of global gene expression can reveal the molecular pathways 1 Department of Pharmacology and Therapeutics, University of relevant to the disease process and identify potential new Liverpool, United Kingdom and 2Precision Therapeutics, Inc., Pittsburgh, Pennsylvania therapeutic targets. The use of this technology for the molecular classification of cancer was recently shown with the identification of an expression profile that was Abstract predictive of patient outcome for B-cell lymphoma (1). We have recently described an ex vivo chemoresponse In addition, this study showed that histologically similar assay for determining chemosensitivity in primary cultures tumors can be differentiated based on their gene expression of human tumors. In this study, we have extended these profiles. Ultimately, these unique patterns of gene expres- experiments in an effort to correlate chemoresponse data sion may be used as guidelines to direct different modes of with gene expression patterns at the level of transcription. therapy. Primary cultures of cells derived from ovarian carcinomas Although it is widely recognized that patients with the of individual patients (n = 6) were characterized using same histologic stage and grade of cancer respond to the ChemoFx assay and classified as either carboplatin therapies differently, few clinical tests can predict indi- sensitive (n = 3) or resistant (n = 3). Three representa- vidual patient responses. The next great challenge will be tive cultures of cells from each individual tumor were then to use the power of post-genomic technology, including subjected to Affymetrix gene chip analysis (n = 18) using microarray analyses, to correlate gene expression patterns U95A human gene chip arrays.
    [Show full text]
  • Specific, Gene Expression Signatures in HIV-1 Infection1
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Qingsheng Li Publications Papers in the Biological Sciences 2009 Microarray Analysis of Lymphatic Tissue Reveals Stage- Specific, Gene Expression Signatures in HIV-1 Infection1 Qingsheng Li University of Minnesota, [email protected] Anthony J. Smith University of Minnesota Timothy W. Schacker University of Minnesota John V. Carlis University of Minnesota Lijie Duan University of Minnesota See next page for additional authors Follow this and additional works at: https://digitalcommons.unl.edu/biosciqingshengli Li, Qingsheng; Smith, Anthony J.; Schacker, Timothy W.; Carlis, John V.; Duan, Lijie; Reilly, Cavan S.; and Haase, Ashley T., "Microarray Analysis of Lymphatic Tissue Reveals Stage- Specific, Gene Expression Signatures in HIV-1 Infection1" (2009). Qingsheng Li Publications. 8. https://digitalcommons.unl.edu/biosciqingshengli/8 This Article is brought to you for free and open access by the Papers in the Biological Sciences at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Qingsheng Li Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Authors Qingsheng Li, Anthony J. Smith, Timothy W. Schacker, John V. Carlis, Lijie Duan, Cavan S. Reilly, and Ashley T. Haase This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/ biosciqingshengli/8 NIH Public Access Author Manuscript J Immunol. Author manuscript; available in PMC 2013 January 23. Published in final edited form as: J Immunol. 2009 August 1; 183(3): 1975–1982. doi:10.4049/jimmunol.0803222. Microarray Analysis of Lymphatic Tissue Reveals Stage- Specific, Gene Expression Signatures in HIV-1 Infection1 $watermark-text $watermark-text $watermark-text Qingsheng Li2,*, Anthony J.
    [Show full text]
  • Factor Expression and Correlate with Specific Transcription in Early Human Precursor B Cell Subsets Ig Gene Rearrangement Steps
    The Journal of Immunology Ig Gene Rearrangement Steps Are Initiated in Early Human Precursor B Cell Subsets and Correlate with Specific Transcription Factor Expression1 Menno C. van Zelm,*† Mirjam van der Burg,* Dick de Ridder,*‡ Barbara H. Barendregt,*† Edwin F. E. de Haas,* Marcel J. T. Reinders,‡ Arjan C. Lankester,§ Tom Re´ve´sz,¶ Frank J. T. Staal,* and Jacques J. M. van Dongen2* The role of specific transcription factors in the initiation and regulation of Ig gene rearrangements has been studied extensively in mouse models, but data on normal human precursor B cell differentiation are limited. We purified five human precursor B cell subsets, and assessed and quantified their IGH, IGK, and IGL gene rearrangement patterns and gene expression profiles. Pro-B cells already massively initiate DH-JH rearrangements, which are completed with VH-DJH rearrangements in pre-B-I cells. Large cycling pre-B-II cells are selected for in-frame IGH gene rearrangements. The first IGK/IGL gene rearrangements were initiated in pre-B-I cells, but their frequency increased enormously in small pre-B-II cells, and in-frame selection was found in immature B cells. Transcripts of the RAG1 and RAG2 genes and earlier defined transcription factors, such as E2A, early B cell factor, E2-2, PAX5, and IRF4, were specifically up-regulated at stages undergoing Ig gene rearrangements. Based on the combined Ig gene rearrangement status and gene expression profiles of consecutive precursor B cell subsets, we identified 16 candidate genes involved in initiation and/or regulation of Ig gene rearrangements. These analyses provide new insights into early human pre- cursor B cell differentiation steps and represent an excellent template for studies on oncogenic transformation in precursor B acute lymphoblastic leukemia and B cell differentiation blocks in primary Ab deficiencies.
    [Show full text]
  • Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib
    Supplementary Online Content Chen G, McQuade JL, Panka DJ, et al. Clinical, molecular and immune analysis of dabrafenib-trametinib combination treatment for metastatic melanoma that progressed during BRAF inhibitor monotherapy: a phase 2 clinical trial. JAMA Oncology. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0509. eMethods. eReferences. eTable 1. Clinical efficacy eTable 2. Adverse events eTable 3. Correlation of baseline patient characteristics with treatment outcomes eTable 4. Patient responses and baseline IHC results eFigure 1. Kaplan-Meier analysis of overall survival eFigure 2. Correlation between IHC and RNAseq results eFigure 3. pPRAS40 expression and PFS eFigure 4. Baseline and treatment-induced changes in immune infiltrates eFigure 5. PD-L1 expression eTable 5. Nonsynonymous mutations detected by WES in baseline tumors This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/30/2021 eMethods Whole exome sequencing Whole exome capture libraries for both tumor and normal samples were constructed using 100ng genomic DNA input and following the protocol as described by Fisher et al.,3 with the following adapter modification: Illumina paired end adapters were replaced with palindromic forked adapters with unique 8 base index sequences embedded within the adapter. In-solution hybrid selection was performed using the Illumina Rapid Capture Exome enrichment kit with 38Mb target territory (29Mb baited). The targeted region includes 98.3% of the intervals in the Refseq exome database. Dual-indexed libraries were pooled into groups of up to 96 samples prior to hybridization.
    [Show full text]
  • Bone Morphogenetic Protein Signaling Regulates Id1 Mediated Neural Stem Cell Quiescence in the Adult Zebrafish Brain Via a Phylogenetically Conserved Enhancer Module
    bioRxiv preprint doi: https://doi.org/10.1101/787804; this version posted February 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Bone morphogenetic protein signaling regulates Id1 mediated neural stem cell quiescence in the adult zebrafish brain via a phylogenetically conserved enhancer module Gaoqun Zhang1§, Marco Ferg1§, Luisa Lübke1, Masanari Takamiya1, Tanja Beil1, Victor Gourain1, Nicolas Diotel2, Uwe Strähle1* and Sepand Rastegar1* Address: 1 Institute of Biological and Chemical Systems-Biological Information Processing (IBCS-BIP), Karlsruhe Institute of Technology (KIT), Postfach 3640, 76021 Karlsruhe, Germany. 2 Université de La Réunion, INSERM, UMR 1188, Diabète athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France. § Authors contributed equally *Correspondence to: [email protected] or [email protected] Keywords: Adult neurogenesis, regeneration, telencephalon, radial glial cell, transcription, cis-regulatory modules, BMP, id1, zebrafish, neural stem cell Running title: id1 Transcriptional Regulation in Neural Stem Cells bioRxiv preprint doi: https://doi.org/10.1101/787804; this version posted February 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract In the telencephalon of adult zebrafish, the inhibitor of DNA binding 1 (id1) gene is expressed in radial glial cells (RGCs), behaving as neural stem cells (NSCs), during constitutive and regenerative neurogenesis. Id1 controls the balance between resting and proliferating states of RGCs by promoting quiescence. Here, we identified a phylogenetically conserved cis-regulatory module (CRM) mediating the specific expression of id1 in RGCs.
    [Show full text]
  • In K-Ras–Mutated Colorectal Cancer
    Published OnlineFirst October 5, 2010; DOI: 10.1158/1535-7163.MCT-10-0376 Molecular Cancer Preclinical Development Therapeutics Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras–Mutated Colorectal Cancer John J. Tentler, Sujatha Nallapareddy, Aik Choon Tan, Anna Spreafico, Todd M. Pitts, M. Pia Morelli, Heather M. Selby, Maria I. Kachaeva, Sara A. Flanigan, Gillian N. Kulikowski, Stephen Leong, John J. Arcaroli, Wells A. Messersmith, and S. Gail Eckhardt Abstract Mutant K-ras activity leads to the activation of the RAS/RAF/MEK/ERK pathway in approximately 44% of colorectal cancer (CRC) tumors. Accordingly, several inhibitors of the MEK pathway are under clinical evaluation in several malignancies including CRC. The aim of this study was to develop and characterize predictive biomarkers of response to the MEK1/2 inhibitor AZD6244 in CRC in order to maximize the clinical utility of this agent. Twenty-seven human CRC cell lines were exposed to AZD6244 and classified according to m > m the IC50 value as sensitive ( 0.1 mol/L) or resistant ( 1 mol/L). All cell lines were subjected to immunoblot- ting for effector proteins, K-ras/BRAF mutation status, and baseline gene array analysis. Further testing was done in cell line xenografts and K-ras mutant CRC human explants models to develop a predictive genomic classifier for AZD6244. The most sensitive and resistant cell lines were subjected to differential gene array and pathway analyses. Members of the Wnt signaling pathway were highly overexpressed in cell lines resistant to AZD6244 and seem to be functionally involved in mediating resistance by shRNA knockdown studies.
    [Show full text]